Our Portfolio

Active Pass Pharmaceuticals

Peter Reiner, VMD, PhD | BC, Canada

Project Overview

  • Biotechnology/For Profit Organization Type
  • $150,000 Funding Amount
  • 1/31/00 — 4/10/02 Project Duration
  • Drug Discovery Program
  • Target Validation Therapeutic Stage
  • Closed Status

Active Pass Pharmaceuticals

Peter Reiner, VMD, PhD | BC, Canada

Brain-Expressed ABC Transporters as Targets for AD Therapeutics

GET IN TOUCH